ArticleBMC infectious diseases2025
Exploring ENPP5 as a diagnostic biomarker for sepsis: a comprehensive bioinformatics analysis.
Article in BMC infectious diseases, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
Abstract
backgroundThe rising mortality rates in sepsis highlight the current lack of reliable therapeutic biomarkers. This study aims to identify markers associated with biological functions to offer new strategies for sepsis diagnosis.
methodsWe conducted differential expression analysis to identify differentially expressed messenger RNAs (DEmRs), long non-coding RNA (DElncRs), and microRNAs (DEmiRs) in sepsis compared to healthy controls. Enrichment analysis was performed using DEmRs, and a lncRNA-miRNA-mRNA competing endogenous RNA network was constructed. Least absolute shrinkage and selection operator (LASSO) and random forest models were applied to identify diagnostic mRNAs. The optimal diagnostic model was determined through decision curve analysis, resulting in the identification of seven hub genes. The key gene, determined by its highest importance and the largest area under the receiver operating characteristics curve (AUC) value, was further validated. Additionally, we analyzed the correlation of the key gene with microenvironment cell infiltration and immune genes.
resultsA total of 4,450 intersected DEmRs (GSE66099, GSE13904, GSE154918, GSE8121) that were significantly involved in the cell cycle. We obtained 13 mRNAs, and further screened seven hub genes, including PPARD, ZSCAN2, ABI2, ENPP5, FMNL3, CD3E, and CAMK4. Subsequently, ENPP5 was as the key gene based on importance and AUC value. Moreover, Neutrophil cells and macrophages had a high abundance in sepsis patients. ENPP5 was positively associated with T cells but negatively associated with mast cells.
conclusionENPP5, identified as a key gene, exhibits significant associations with immune cell infiltration and immune-related genes. This suggests its potential role as a biomarker for novel therapeutic strategies in sepsis.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.